Japanese drugmakers are accelerating their development of vaccines for the novel coronavirus even as foreign rivals seem to be leading the global race, with the government pushing homegrown efforts to secure stable supplies for the country.Around 125 vaccines are currently under development globally, including 10 in human testing as of May 27, according to the World Health Organization. But given the expected surge in demand, the Japanese government is concerned that foreign vaccines would be limited in supply and not widely available for people in Japan.Related coverage:READ FULL ARTICLE